Cargando…
Development and Validation of a Novel Metabolic Signature-Based Prognostic Model for Uveal Melanoma
PURPOSE: Uveal melanoma (UM) is the most common primary malignant tumor with poor prognosis. The role of metabolism-related genes in the prognosis of UM remains unrevealed. This study aimed to establish and validate a prognostic prediction model for UM based on metabolism-related genes. METHODS: Gen...
Autores principales: | Shi, Ke, Li, Xinxin, Zhang, Jingfa, Sun, Xiaodong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100464/ https://www.ncbi.nlm.nih.gov/pubmed/35536719 http://dx.doi.org/10.1167/tvst.11.5.9 |
Ejemplares similares
-
Development and validation of an immune and stromal prognostic signature in uveal melanoma to guide clinical therapy
por: Gong, Qianwen, et al.
Publicado: (2020) -
Prognostic Implications of Novel Ten-Gene Signature in Uveal Melanoma
por: Luo, Huan, et al.
Publicado: (2020) -
A Novel Four Genes of Prognostic Signature for Uveal Melanoma
por: Liu, Yan, et al.
Publicado: (2022) -
A Novel 8-Gene Prognostic Signature for Survival Prediction of Uveal Melanoma
por: Tang, Zhongjun, et al.
Publicado: (2021) -
Development and External Validation of a Prognostic Nomogram for Metastatic Uveal Melanoma
por: Valpione, Sara, et al.
Publicado: (2015)